List view / Grid view

News

MRC Technology and Yabao Pharmaceuticals announce exclusive partnership in China to develop novel therapeutics for Parkinson’s disease

24 November 2014 | By MRC Technology / Yabao Pharmaceuticals

MRC Technology and Yabao Pharmaceutical Co, Inc. today announced an exclusive license agreement to discover, develop and commercialise innovative compounds targeting a specific kinase involved in neurodegeneration, with the aim of developing novel therapeutics for the treatment of Parkinson’s disease...

Cardio3 BioSciences acquires CorQuest Medical Inc.

6 November 2014 | By Cardio3 BioSciences

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces that it has acquired U.S.-based CorQuest Medical Inc. CorQuest Medical specializes in the development of innovative devices and technologies for cardiac surgery...